Related Experiment Video
Updated: Feb 13, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1
Hongsheng Wang1, Wei Sun2, Mengxiong Sun2
1Department of Orthopedics, Shanghai General Hospital, School of Medicine Shanghai Jiao Tong University, Shanghai, China; Shanghai Bone Tumor Institution, Shanghai, China; Department of Orthopedics, Yangpu Hospital, Tongji University, Shanghai, China.
Abstract:
Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. The abilities of chemotherapy resistance are major roadblock in the successful treatment of OS. The clarification of mechanism regarding cell survival during OS chemotherapy are important. Here, we examined HER4 expression by immunohistochemistry in a large series of OS tissues, and found HER4 expression correlated with tumor characteristics and patient survival rates. HER4 knockdown by shRNA inhibited OS cell growth and tumorigenesis, and induced cell senescence and apoptosis in vitro and in vivo. We demonstrated that HER4 expression upregulated in the adverse conditions, such as serum starvation and sphere culture. Moreover, HER4 knockdown cells became more sensitive in stressful conditions such as loss of attachment, cytotoxic agents or nutrition insufficiency. Mechanism studies revealed that HER4 interacted with NDRG1, and NDRG1 overexpression could antagonize HER4 knockdown-mediated cell growth and apoptosis in stressed conditions. There was a positive correlation between HER4 and NDRG1 immunoreactivity in OS patients. Together, our present study shows that HER4 and/or NDRG1 might play a critical role for the cell survival and chemo-resistance of OS, and could be used as potential therapeutic targets in OS.
Insights
HER4 and NDRG1 proteins are crucial for osteosarcoma (OS) cell survival and chemotherapy resistance. Targeting these proteins may offer new therapeutic strategies for treating this common childhood bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Osteosarcoma (OS) is the most frequent primary bone malignancy in children and adolescents.
- Chemotherapy resistance significantly hinders effective OS treatment.
- Understanding the mechanisms of OS cell survival during chemotherapy is critical.
Purpose of the Study:
- To investigate the role of HER4 expression in osteosarcoma.
- To elucidate the mechanisms by which HER4 influences OS cell survival and chemoresistance.
- To explore the potential of HER4 and NDRG1 as therapeutic targets in OS.
Main Methods:
- Immunohistochemistry was used to assess HER4 expression in OS tissues.
- HER4 knockdown was performed using shRNA in vitro and in vivo.
- Cellular responses to stress conditions and interactions between HER4 and NDRG1 were analyzed.
Main Results:
- HER4 expression correlated with OS tumor characteristics and patient survival.
- HER4 knockdown inhibited OS cell growth, induced senescence and apoptosis, and increased sensitivity to stress.
- HER4 interacts with NDRG1, which can counteract HER4 knockdown effects in stressed conditions.
Conclusions:
- HER4 plays a significant role in OS cell survival and chemoresistance, particularly under adverse conditions.
- The interaction between HER4 and NDRG1 is important for OS cell survival.
- HER4 and NDRG1 represent potential therapeutic targets for osteosarcoma treatment.
Related Concept Videos
The Eukaryotic Promoter Region
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Comparing the Survival Analysis of Two or More Groups
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...

